Zannad Zannad F F Ferreira Ferreira JP JP Pocock Pocock SJ SJ SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials Lancet Lancet 2020 2020 396 396 10254 10254 819 819 829 829 10.1016/S0140-6736(20)31824-9 10.1016/S0140-6736(20)31824-9 supplied-pmid 32877652? This evidence concerns the gene SLC5A2 and heart failure.